Anemia of inflammation (AI), also known as anemia of chronic disease (ACD), is regarded
as the most frequent anemia in hospitalized and chronically ill patients. It is prevalent in …

Abstract Iron deficiency anemia affects> 1.2 billions individuals worldwide, and iron
deficiency in the absence of anemia is even more frequent. Total-body (absolute) iron …

Background Intravenous iron is a standard treatment for patients undergoing hemodialysis,
but comparative data regarding clinically effective regimens are limited. Methods In a …

Iron is an essential element that is indispensable for life. The delicate physiological body
iron balance is maintained by both systemic and cellular regulatory mechanisms. The iron …

Anemia of inflammation (AI) is a highly prevalent comorbidity in patients affected by chronic
inflammatory disorders, such as chronic kidney disease, inflammatory bowel disease, or …

Background Approximately 30%–45% of patients with nondialysis CKD have iron deficiency.
Iron therapy in CKD has focused primarily on supporting erythropoiesis. In patients with or …

Anemia is a common complication of chronic kidney disease, affecting the quality of life of
patients. Among various factors, such as iron and erythropoietin deficiency, reduced red …

Iron deficiency is frequent in patients with chronic inflammatory conditions (eg, chronic heart
failure, chronic kidney disease, cancers, and bowel inflammatory diseases). Indeed, high …

Iron is a trace element necessary for cell growth, development, and cellular homeostasis, but
insufficient or excessive level of iron is toxic. Intracellularly, sufficient amounts of iron are …

Iron deficiency is a common cause of morbidity and can arise as a consequence or
complication from many diseases. The use of intravenous iron has increased significantly in …